A Synthetic Vaccine

Synthetic biology could help hasten vaccine development, writes Susan Young at MIT's Technology Review. She writes that Novartis is trying out chemically synthesizing viral genomes to grow in tissue culture rather than the standard approach of growing flu viruses up in chicken eggs for vaccine production.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.